Wockhardt Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹888.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.55 per cent from ₹782.00 crore. This corresponds to a year-on-year *(YoY) growth of 23.16 per cent.
Operating Profit
Operating Profit stands at ₹167.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.18 per cent from ₹178.00 crore. This corresponds to a year-on-year *(YoY) growth of 30.47 per cent.
PBDT
PBDT stands at ₹132.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.33 per cent from ₹144.00 crore. This corresponds to a year-on-year *(YoY) growth of 73.68 per cent.
Profit Before Tax
Profit Before Tax stands at ₹67.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 26.37 per cent from ₹91.00 crore. This corresponds to a year-on-year *(YoY) growth of 219.05 per cent.
Net Profit
Net Profit stands at ₹61.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 25.61 per cent from ₹82.00 crore. This represents a 205.00 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Wockhardt Ltd Earnings
- YOY
- QOQ
Wockhardt Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Wockhardt Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Wockhardt Ltd Financial Reports
Wockhardt Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Wockhardt | 2.03% | -1.20% | 21.78% | 4.49% | 9.73% | 4.85% |
| J B Chemicals & | 2.30% | 3.83% | -0.64% | 11.13% | 20.80% | 29.22% |
| Emcure Pharma | -0.65% | 2.12% | 2.10% | 13.51% | 21.61% | 61.19% |
| Gland Pharma | 3.44% | -1.37% | 4.48% | -1.45% | -6.84% | 25.50% |
| Sai Life | 4.17% | 6.05% | 10.00% | 28.96% | 16.43% | 49.50% |
| Piramal Pharma | 2.15% | 9.81% | 23.85% | 9.99% | -17.16% | -20.28% |
| Pfizer | 1.17% | 0.58% | 1.49% | 4.15% | -8.90% | 12.46% |
Company Info
Company Information
Executive Chairman : H F Khorakiwala
Managing Director : Murtaza H Khorakiwala
Executive Director : Huzaifa H Khorakiwala
Independent Director : Vinesh Kumar Jairath
Non-Executive & Non-Independent Director : Zahabiya Khorakiwala
Independent Director : Akhilesh Gupta
Independent Director : Amelia Fernandes
Company Sec. & Compli. Officer : Rashmi Mamtura
Independent Director : Ahmad Javed
Additional Director : Om Prakash Bhatt